Safety and Efficacy of Reslizumab for Children and Adolescents With Eosinophilic Esophagitis Treated Over Nine Years. (Q47412418)

From Wikidata
Jump to navigation Jump to search
scientific article published on 22 November 2017
edit
Language Label Description Also known as
English
Safety and Efficacy of Reslizumab for Children and Adolescents With Eosinophilic Esophagitis Treated Over Nine Years.
scientific article published on 22 November 2017

    Statements

    Safety and Efficacy of Reslizumab for Children and Adolescents With Eosinophilic Esophagitis Treated Over Nine Years. (English)
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit